Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview.

McCann TS, Sobral LM, Self C, Hsieh J, Sechler M, Jedlicka P.

Expert Opin Ther Targets. 2019 Feb 13. doi: 10.1080/14728222.2019.1580692. [Epub ahead of print]

PMID:
30759030
2.

Dental root size in bats with diets of different hardness.

Self CJ.

J Morphol. 2015 Sep;276(9):1065-74. doi: 10.1002/jmor.20400. Epub 2015 May 26.

PMID:
26011087
3.

Intra- and interseasonal autoregressive prediction of dengue outbreaks using local weather and regional climate for a tropical environment in Colombia.

Eastin MD, Delmelle E, Casas I, Wexler J, Self C.

Am J Trop Med Hyg. 2014 Sep;91(3):598-610. doi: 10.4269/ajtmh.13-0303. Epub 2014 Jun 23.

4.

Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.

Ji N, Somanaboeina A, Dixit A, Kawamura K, Hayward NJ, Self C, Olson GL, Forsthuber TG.

J Immunol. 2013 Nov 15;191(10):5074-84. doi: 10.4049/jimmunol.1300407. Epub 2013 Oct 11.

5.

An evaluation of the 4-H Health Rocks program: implications for program improvement.

Self C, Morgan AC, Fuhrman NE, Navarro M.

J Drug Educ. 2013;43(1):49-63.

PMID:
24855883
6.

Reduction of non-specific binding in immunoassays requiring long incubations.

Farajollahi MM, Cook DB, Hamzehlou S, Self CH.

Scand J Clin Lab Invest. 2012 Nov;72(7):531-9. doi: 10.3109/00365513.2012.702352. Epub 2012 Aug 31.

PMID:
22939169
7.

Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy.

Lountos GT, Jobson AG, Tropea JE, Self CR, Zhang G, Pommier Y, Shoemaker RH, Waugh DS.

J Struct Biol. 2011 Dec;176(3):292-301. doi: 10.1016/j.jsb.2011.09.008. Epub 2011 Sep 22.

8.

X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket.

Lountos GT, Jobson AG, Tropea JE, Self CR, Zhang G, Pommier Y, Shoemaker RH, Waugh DS.

FEBS Lett. 2011 Oct 20;585(20):3245-9. doi: 10.1016/j.febslet.2011.08.050. Epub 2011 Sep 7.

9.

Disruption of protein kinase A localization using a trans-activator of transcription (TAT)-conjugated A-kinase-anchoring peptide reduces cardiac function.

Patel HH, Hamuro LL, Chun BJ, Kawaraguchi Y, Quick A, Rebolledo B, Pennypacker J, Thurston J, Rodriguez-Pinto N, Self C, Olson G, Insel PA, Giles WR, Taylor SS, Roth DM.

J Biol Chem. 2010 Sep 3;285(36):27632-40. doi: 10.1074/jbc.M110.146589. Epub 2010 Jun 26.

10.

Light-activated antibodies in the fight against primary and metastatic cancer.

Thompson S, Self AC, Self CH.

Drug Discov Today. 2010 Jun;15(11-12):468-73. doi: 10.1016/j.drudis.2010.04.006. Epub 2010 May 8. Review.

PMID:
20450983
11.
12.

Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2.

Arico-Muendel CC, Benjamin DR, Caiazzo TM, Centrella PA, Contonio BD, Cook CM, Doyle EG, Hannig G, Labenski MT, Searle LL, Lind K, Morgan BA, Olson G, Paradise CL, Self C, Skinner SR, Sluboski B, Svendsen JL, Thompson CD, Westlin W, White KF.

J Med Chem. 2009 Dec 24;52(24):8047-56. doi: 10.1021/jm901260k.

PMID:
19929003
13.

Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide].

Jobson AG, Lountos GT, Lorenzi PL, Llamas J, Connelly J, Cerna D, Tropea JE, Onda A, Zoppoli G, Kondapaka S, Zhang G, Caplen NJ, Cardellina JH 2nd, Yoo SS, Monks A, Self C, Waugh DS, Shoemaker RH, Pommier Y.

J Pharmacol Exp Ther. 2009 Dec;331(3):816-26. doi: 10.1124/jpet.109.154997. Epub 2009 Sep 9.

14.

Structural analysis of human rib fracture and implications for forensic interpretation.

Daegling DJ, Warren MW, Hotzman JL, Self CJ.

J Forensic Sci. 2008 Nov;53(6):1301-7. doi: 10.1111/j.1556-4029.2008.00876.x. Epub 2008 Sep 16.

PMID:
18798775
15.

The construction and in vitro testing of photo-activatable cancer targeting folated anti-CD3 conjugates.

Thompson S, Dessi J, Self CH.

Biochem Biophys Res Commun. 2008 Feb 8;366(2):526-31. Epub 2007 Dec 7.

PMID:
18068664
16.

Light activation of anti-CD3 in vivo reduces the growth of an aggressive ovarian carcinoma.

Thompson S, Stewart R, Smith JA, Self CH.

ChemMedChem. 2007 Nov;2(11):1591-3. No abstract available.

PMID:
17979166
17.

Light-directed activation of human T-cells.

Self CH, Self AC, Smith JA, Self DJ, Thompson S.

ChemMedChem. 2007 Nov;2(11):1587-90. No abstract available.

PMID:
17979165
18.

Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assay.

Hamuro L, Zhang G, Tucker TJ, Self C, Strittmatter WJ, Burke JR.

Assay Drug Dev Technol. 2007 Oct;5(5):629-36.

PMID:
17939755
19.

The construction of a functional photoactivatable cancer targeting bispecific antibody conjugate.

Thompson S, Fawcett MC, Self CH.

ChemMedChem. 2007 Aug;2(8):1162-4. No abstract available.

PMID:
17506043
20.

How specific are therapeutic monoclonal antibodies?

Self CH, Thompson S.

Lancet. 2006 Apr 1;367(9516):1038-1039. doi: 10.1016/S0140-6736(06)68396-7. No abstract available.

PMID:
16581388
21.

A simple procedure for the photoregulation of chymotrypsin activity.

Thompson S, Fawcett MC, Pulman LB, Self CH.

Photochem Photobiol Sci. 2006 Mar;5(3):326-30. Epub 2006 Jan 19.

PMID:
16520868
22.

Effective transscleral delivery of two retinal anti-angiogenic molecules: carboxyamido-triazole (CAI) and 2-methoxyestradiol (2ME2).

Cruysberg LP, Franklin AJ, Sanders J, Self C, Yuan P, Csaky KG, Robinson MR, Kohn EC, Edelhauser HF.

Retina. 2005 Dec;25(8):1022-31.

PMID:
16340533
23.

Social exclusion in clients with comorbid mental health and substance misuse problems.

Todd J, Green G, Harrison M, Ikuesan BA, Self C, Pevalin DJ, Baldacchino A.

Soc Psychiatry Psychiatr Epidemiol. 2004 Jul;39(7):581-7.

PMID:
15243697
24.

The usefulness of buccal swabs for mutation screening in patients with suspected corneal dystrophies.

Aldave AJ, Yellore VS, Self CA, Holsclaw D, Small K.

Ophthalmology. 2004 Jul;111(7):1407-9.

PMID:
15234146
25.

The application of statistical process control to horizontal strabismus surgery.

Self CA, Enzenauer RW.

J AAPOS. 2004 Apr;8(2):165-70.

PMID:
15088051
26.

Defining dual diagnosis of mental illness and substance misuse: some methodological issues.

Todd J, Green G, Harrison M, Ikuesan BA, Self C, Baldacchino A, Sherwood S.

J Psychiatr Ment Health Nurs. 2004 Feb;11(1):48-54.

PMID:
14723639
27.

Designing isoform-specific peptide disruptors of protein kinase A localization.

Burns-Hamuro LL, Ma Y, Kammerer S, Reineke U, Self C, Cook C, Olson GL, Cantor CR, Braun A, Taylor SS.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4072-7. Epub 2003 Mar 19.

28.

The first monoclonal antibody-based, matrix-resistant immunoassay for the carbamate herbicide asulam, in water.

Spoors JA, Winger LA, Siew LK, Dessi JL, Jennens L, Self CH.

J Environ Monit. 2002 Dec;4(6):917-21.

PMID:
12509045
29.

Corticotropin-releasing hormone binding to the syncytiotrophoblast membranes.

Saeed B, Fawcett M, Self C.

Eur J Clin Invest. 2001 Feb;31(2):125-30.

PMID:
11168450
30.

Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.

Fleming SC, Smith S, Knowles D, Skillen A, Self CH.

J Clin Pathol. 1998 Nov;51(11):825-30.

31.

Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls.

Cook DB, Bustamam AA, Brotherick I, Shenton BK, Self CH.

Clin Chem. 1999 Feb;45(2):292-5. No abstract available.

32.

Major improvement of lectin-based assays through choice of cation and optimization of cation concentration.

Farajollahi MM, Cook DB, Self CH.

Anal Biochem. 1998 Jul 15;261(1):118-21. No abstract available.

PMID:
9683521
33.

A sandwich hybridization assay employing enzyme amplification for termination of specific ribosomal RNA from unpurified cell lysates.

Wicks B, Cook DB, Barer MR, O'Donnell AG, Self CH.

Anal Biochem. 1998 Jun 1;259(2):258-64.

PMID:
9618205
34.

Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

Panina-Bordignon P, Mazzeo D, Lucia PD, D'Ambrosio D, Lang R, Fabbri L, Self C, Sinigaglia F.

J Clin Invest. 1997 Sep 15;100(6):1513-9.

35.

Characterization of corticotropin-releasing hormone binding sites in the human placenta.

Saeed BO, Weightman DR, Self CH.

J Recept Signal Transduct Res. 1997 Jul;17(4):647-66.

PMID:
9220373
36.
37.
38.

Light activatable antibodies: models for remotely activatable proteins.

Self CH, Thompson S.

Nat Med. 1996 Jul;2(7):817-20.

PMID:
8673931
39.

Advances in immunoassay technology.

Self CH, Cook DB.

Curr Opin Biotechnol. 1996 Feb;7(1):60-5. Review.

PMID:
8742378
40.

Studies on photocleavable nitrobenzyl-bovine serum albumin conjugates.

Self CH, Fawcett MC, Spoors JA, Pulman LB, Thompson S.

Biochem Soc Trans. 1995 May;23(2):156S. No abstract available.

PMID:
7672187
41.

The modulation of protein A-IgG(Fc) binding by the reversible addition of 2-nitrobenzyl groups.

Thompson S, Fawcett MC, Spoors JA, Self CH.

Biochem Soc Trans. 1995 May;23(2):155S. No abstract available.

PMID:
7672186
42.

Glycation of monoclonal antibodies impairs their ability to bind antigen.

Kennedy DM, Skillen AW, Self CH.

Clin Exp Immunol. 1994 Nov;98(2):245-51.

44.

Photocleavable nitrobenzyl-protein conjugates.

Thompson S, Spoors JA, Fawcett MC, Self CH.

Biochem Biophys Res Commun. 1994 Jun 30;201(3):1213-9.

PMID:
8024564
45.
46.

Glycation increases the vascular clearance rate of IgG in mice.

Kennedy DM, Skillen AW, Self CH.

Clin Exp Immunol. 1993 Dec;94(3):447-51.

47.

Colorimetric assay of glycoprotein glycation free of interference from glycosylation residues.

Kennedy DM, Skillen AW, Self CH.

Clin Chem. 1993 Nov;39(11 Pt 1):2309-11.

50.

Monosaccharide composition of haptoglobin purified from alcoholic cirrhotic and control sera determined by HPAE.

Mann AC, Thompson S, Record CO, Self CH, Turner GA.

Biochem Soc Trans. 1993 May;21(2):214S. No abstract available.

PMID:
8359464

Supplemental Content

Support Center